Paris - Delayed Quote EUR

Boiron SA (BOI.PA)

34.90 -0.40 (-1.13%)
At close: 5:35 PM GMT+2
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
493,248.00
493,248.00
534,239.00
455,201.00
513,582.00
--
Cost of Revenue
135,165.00
135,165.00
154,513.00
127,579.00
118,841.00
--
Gross Profit
358,083.00
358,083.00
379,726.00
327,622.00
394,741.00
--
Operating Expense
317,273.00
317,273.00
323,099.00
288,080.00
325,011.00
--
Operating Income
40,810.00
40,810.00
56,627.00
39,542.00
69,730.00
--
Net Non Operating Interest Income Expense
2,198.00
2,198.00
-722.00
789.00
-1,146.00
--
Pretax Income
46,851.00
46,851.00
59,199.00
46,113.00
37,217.00
--
Tax Provision
12,911.00
12,911.00
14,919.00
17,554.00
11,008.00
--
Net Income Common Stockholders
35,827.00
35,827.00
44,673.00
28,556.00
26,209.00
--
Diluted NI Available to Com Stockholders
35,827.00
35,827.00
44,673.00
28,556.00
26,209.00
--
Basic EPS
2.06
2.06
2.57
1.63
1.50
--
Diluted EPS
2.06
2.06
2.57
1.63
1.50
--
Basic Average Shares
17,362.22
17,362.22
17,389.17
17,516.47
17,508.15
--
Diluted Average Shares
17,362.22
17,362.22
17,389.17
17,516.47
17,508.15
--
Total Operating Income as Reported
42,290.00
42,290.00
63,448.00
46,842.00
38,185.00
--
Total Expenses
452,438.00
452,438.00
477,612.00
415,659.00
443,852.00
--
Net Income from Continuing & Discontinued Operation
35,827.00
35,827.00
44,673.00
28,556.00
26,209.00
--
Normalized Income
37,172.25
37,172.25
46,453.01
25,396.62
46,719.34
--
Interest Income
7,462.00
7,462.00
1,817.00
590.00
459.00
--
Interest Expense
1,191.00
1,191.00
607.00
359.00
348.00
--
Net Interest Income
2,198.00
2,198.00
-722.00
789.00
-1,146.00
--
EBIT
48,042.00
48,042.00
59,806.00
46,472.00
37,565.00
--
EBITDA
73,667.00
73,667.00
77,020.00
64,596.00
106,820.00
--
Reconciled Cost of Revenue
135,165.00
135,165.00
154,513.00
127,579.00
118,841.00
--
Reconciled Depreciation
25,625.00
25,625.00
17,214.00
18,124.00
69,255.00
--
Net Income from Continuing Operation Net Minority Interest
35,827.00
35,827.00
44,673.00
28,556.00
26,209.00
--
Total Unusual Items Excluding Goodwill
4,077.00
4,077.00
3,004.00
5,104.00
-29,134.00
--
Total Unusual Items
8,374.00
8,374.00
7,031.00
5,104.00
-29,134.00
--
Normalized EBITDA
65,293.00
65,293.00
69,989.00
59,492.00
135,954.00
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
Tax Effect of Unusual Items
1,125.25
1,125.25
757.01
1,944.62
-8,623.66
--
12/31/2019 - 1/3/1991

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

U5Z.F Vertical Peak Holdings Inc.
0.0005
0.00%
 
RPG.F Regent Pacific Group Limited
0.0675
+3.85%
 
LDE.DU Lifecore Biomedical Inc
5.35
-0.93%
 
RPGLF Regent Pacific Group Limited
0.0600
-11.76%
 
CRPGF CHINA RESOURCES PHARMACEUTICAL
0.5600
0.00%
 
MITPF Mithra Pharmaceuticals SA
6.75
-12.90%
 
DCPXF DanCann Pharma A/S
0.0100
0.00%
 
CSWYF China Shineway Pharmaceutical Group Limited
1.0040
+8.51%
 
CSWYY China Shineway Pharmaceutical Group Limited
22.54
0.00%
 
C1P.F Consun Pharmaceutical Group Limited
0.9500
+6.15%